BUZZ-Australia's Singular Health hits two-month high on FDA clearance for medical imaging tech

Reuters
01/13
BUZZ-Australia's Singular Health hits two-month high on FDA clearance for medical imaging tech

** Shares of Australia's Singular Health Group SHG.AX rise as much as 15.4% to A$0.30, their highest level November 13

** The biotech co says the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for 3DICOM MD® Cloud, which is a cloud evolution of co's FDA approved medical imaging device

** 3DICOM MD® Cloud has been cleared as a Class II Software as a Medical Device, enabling marketing and clinical use of the platform in the United States, co says

** Stock gained 13.3% in 2025, and is up 7.8% YTD

(Reporting by Shruti Agarwal in Bengaluru)

((Shruti.Agarwal@thomsonreuters.com))

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10